Question Bank › Strong facts, held-back story

Strong facts, held-back story

Strong facts, held-back story: management reports concrete strengthening but deliberately keeps expectations below it

Calls Tested
460
Answered YES
101
Hit Rate
22%
rare by design

Full Truck Alliance Co. Ltd. (YMM) — this company's answers

NO on the Q2 2022 call 2022-08-25 C+
The model's full reasoning — Q2 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否同时(1)报告了实际发生的业务改善(如订单、交易量、客户、活动、胜利、利用率或产出等),并且(2)明显抑制了这种改善,即故意将预期、预测或框架设定得比报告的事实更保守。 首先,检查第一部分:管理层是否报告了实际发生的、已经出现的业务改善?在电话会议中,管理层提到: - GTV和完成订单量环比增长22.8%和10.7%(第二季度) - 平均托运人MAU环比增长7.7%,同比持平 - 总净收入同比增长49.3%,环比增长25.3% - 非GAAP调整后净利润同比增长168.1% - 佣金收入同比增长116.2% - 佣金GTV渗透率达到50% - 用户留存率稳定,12个月托运人留存率约85% - 新用户注册恢复后,已转化约30万月活跃托运人和30万月活跃卡车司机 这些是实际发生的、报告中的改善。所以第一部分满足。 第二部分:管理层是否明显抑制了这种改善?即是否故意保持预期或框架比事实更保守?在电话会议中,管理层提到: - 尽管有这些改善,但管理层强调外部不确定性,如疫情反复,对下半年仍面临挑战。 - 在展望第三季度时,给出了收入指引,同比增长32.9%至39.2%,但这是基于当前初步看法,并强调疫情的不确定性。 - 管理层提到“我们预计整体履约率在下半年将进一步改善”,但这是预期,不是抑制。 - 管理层在回答关于佣金规则时,表示“我们相信这一公告不会影响我们的变现进程”,但未明确抑制。 - 在回答关于运费率时,管理层说“随着疫情缓解和新用户注册恢复,我们预计运费率将缓慢下降”,这是预期,不是抑制。 - 在回答关于销售和营销费用时,管理层说“我们预计销售和营销费用将增加”,但未抑制。 关键点:管理层是否在报告强劲结果的同时,故意压低预期?在电话会议中,管理层多次提到“外部不确定性”、“疫情反复”、“挑战”等,但这些都是实际存在的风险,并非故意抑制。管理层没有明确说“尽管结果强劲,但我们保持谨慎”之类的表述。相反,管理层在展望中给出了增长指引,并提到“我们期待利用更多增长机会”。 此外,管理层在回答关于佣金规则时,说“我们相信这一公告不会影响我们的变现进程”,这似乎是在安抚,而不是抑制。在回答关于用户增长时,管理层提到“我们预计持续增长”,这也不是抑制。 因此,没有看到管理层明显抑制故事。管理层报告了强劲结果,但同时也提到了外部挑战,但这是合理的风险提示,并非故意压低预期。管理层没有说“结果比我们预期的好,但我们不提高指引”之类的表述。实际上,管理层给出了第三季度指引,同比增长约33-39%,这看起来是合理的,没有明显低于事实。 因此,我认为管理层没有明显抑制故事。所以答案应为NO。 但让我们再仔细看:管理层是否在报告强劲结果的同时,故意保持保守?例如,在提到新用户注册恢复后,管理层说“我们已成功转化了约30万新月活跃托运人和近30万新月活跃卡车司机”,但随后说“展望下半年,我们仍专注于提供更有价值的产品和服务”,这似乎是在强调未来工作,而不是抑制。没有明确说“尽管我们看到了强劲增长,但我们不会提高预期”。 在回答关于佣金规则时,管理层说“我们相信这一公告不会影响我们的变现进程”,这似乎是在说规则不会影响,而不是抑制。 在回答关于运费率时,管理层说“我们预计运费率将缓慢下降”,这是预期,不是抑制。 因此,我认为没有明显的抑制。所以答案应为NO。 但问题要求严格:只有两个条件都满足才回答YES。这里可能不满足第二个条件。 因此,最终答案:NO。

← Back to the full YMM analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management BOTH (1) report concrete, already-occurring strength in the business — real improvement in the recent period such as rising orders, volumes, customers, activity, wins, utilization, or output, described as actually happening now rather than hoped for — AND (2) visibly HOLD THE STORY BACK from that strength — deliberately keeping stated expectations, forecasts, or framing more modest than the reported facts would support? Answer YES when both halves come through in management's own words as one coherent posture, in whatever form fits the business. The RESTRAINT half may show up in many ways, and any genuine expression of it counts — for example: management declining to raise, or raising only modestly, its outlook despite results plainly running ahead of it; management explicitly cautioning against extrapolating or annualizing the strong period even while confirming the strength is real; management choosing not to call the improvement a trend yet, saying it wants more quarters of evidence before it will; management emphasizing risks, execution work still ahead, or reasons for prudence at the very moment the underlying numbers are strengthening; management describing demand or momentum stronger than what it has built into its own plan or guidance; or management answering bullish analyst framings by talking the enthusiasm DOWN rather than up. What matters is the direction of the gap: the facts reported are running AHEAD of the story management is willing to tell, and the modesty is management's own deliberate choice — a stance of under-promising — rather than a response to genuine deterioration. Answer NO if the reported period is weak, mixed, or merely stabilizing, so there is no real strength for the story to lag. NO if management is promotional or freely extrapolates the strength — raising expectations in line with or beyond the results — however justified. NO if the caution reflects actual visible deterioration, softening demand, or specific problems management describes, rather than deliberate restraint amid strength. NO if the conservatism is only boilerplate risk language, standard safe-harbor phrasing, or routine 'prudent guidance' wording without a visible gap between reported facts and stated expectations. NO if the restraint is merely management declining to comment on distant years in the ordinary way. NO if the posture appears only in an analyst's characterization (such as calling guidance conservative) that management does not itself substantiate in how it talks about the business. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
GL Globe Life Inc. Q1 2024 2024-04-23 F
PBR Petróleo Brasileiro S.A. - Petrobras Q4 2023 2024-03-08 D
NICE NICE Ltd. Q4 2023 2024-02-22 B+
DXCM DexCom, Inc. Q4 2023 2024-02-08 B+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
MET MetLife, Inc. Q4 2023 2024-02-01 B+
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
AEP American Electric Power Company, Inc. Q3 2023 2023-11-02 C+
PNNT PennantPark Investment Corporation Q3 2023 2023-08-10 B+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
SPIR Spire Global, Inc. Q1 2023 2023-05-10 B
THS TreeHouse Foods, Inc. Q1 2023 2023-05-08 B+
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
CALX Calix, Inc. Q1 2023 2023-04-20 C+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
ICL ICL Group Ltd Q3 2022 2022-11-09 B+
MEC Mayville Engineering Company, Inc. Q3 2022 2022-11-05 B+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
CIVB Civista Bancshares, Inc. Q2 2022 2022-07-31 B
LIN Linde plc Q2 2022 2022-07-28 B+
PRGS Progress Software Corporation Q2 2022 2022-06-28 B+
SQM Sociedad Química y Minera de Chile S.A. Q1 2022 2022-05-19 C+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
FARM Farmer Bros. Co. Q3 2022 2022-05-07 D
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
VVV Valvoline Inc. Q1 2022 2022-02-09 C+
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
LC LendingClub Corporation Q4 2021 2022-01-26 A
ALHC Alignment Healthcare, Inc. Q3 2021 2021-11-06 B+
WMB The Williams Companies, Inc. Q3 2021 2021-11-02 B
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
MD Pediatrix Medical Group, Inc. Q3 2021 2021-10-28 B
CPRX Catalyst Pharmaceuticals, Inc. Q2 2021 2021-08-10 C+
AMC AMC Entertainment Holdings, Inc. Q2 2021 2021-08-09 D
UFI Unifi, Inc. Q4 2021 2021-08-07 B
CRS Carpenter Technology Corporation Q4 2021 2021-08-01 A
AX Axos Financial, Inc. Q4 2021 2021-07-29 C+
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
JPM JPMorgan Chase & Co. Q2 2021 2021-07-13 A
T AT&T Inc. Q3 2018 2018-10-24 C+
CP Canadian Pacific Railway Limited Q2 2018 2018-07-19 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
HPE Hewlett Packard Enterprise Company Q2 2018 2018-05-22 B+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
FOSL Fossil Group, Inc. Q1 2018 2018-05-08 C
BCOV Brightcove Inc. Q1 2018 2018-04-26 B+
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
HLX Helix Energy Solutions Group, Inc. Q1 2018 2018-04-24 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
PCRX Pacira BioSciences, Inc. Q4 2017 2018-02-28 C
TSLX Sixth Street Specialty Lending, Inc. Q4 2017 2018-02-22 C+
LII Lennox International Inc. Q4 2017 2018-02-06 B+
UNH UnitedHealth Group Incorporated Q4 2017 2018-01-16 A
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
HTLF Heartland Financial USA, Inc. Q3 2017 2017-10-30 B+
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
PII Polaris Inc. Q3 2017 2017-10-24 C+
BCE BCE Inc. Q2 2017 2017-08-05 B+
BIIB Biogen Inc. Q2 2017 2017-07-25 B
ABM ABM Industries Incorporated Q2 2017 2017-06-08 B
DAN Dana Incorporated Q1 2017 2017-05-02 B
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C
AAT American Assets Trust, Inc. Q4 2016 2017-02-15 C+
BDC Belden Inc. Q4 2016 2017-02-02 B
BMO Bank of Montreal Q4 2016 2016-12-06 B
FNV Franco-Nevada Corporation Q3 2016 2016-11-08 B+
WAT Waters Corporation Q3 2016 2016-10-25 C
BOH Bank of Hawaii Corporation Q3 2016 2016-10-24 A
MAT Mattel, Inc. Q3 2016 2016-10-19 C
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
VRNS Varonis Systems, Inc. Q2 2016 2016-08-09 B+
CGNX Cognex Corporation Q2 2016 2016-08-01 A
TRV The Travelers Companies, Inc. Q2 2016 2016-07-21 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
INGR Ingredion Incorporated Q1 2016 2016-05-01 B+
SPR Spirit AeroSystems Holdings, Inc. Q1 2016 2016-04-29 D
ACCO ACCO Brands Corporation Q1 2016 2016-04-27 B+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
CAL Caleres, Inc. Q4 2015 2016-03-15 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
HD The Home Depot, Inc. Q4 2015 2016-02-23 A
JHX James Hardie Industries plc Q3 2016 2016-02-19 B+

How the model reasoned

GTES · Q4 2021 → YESThe question is: Does management BOTH report concrete, already-occurring strength AND visibly HOLD THE STORY BACK from that strength? YES Management reports concrete, already-occurring strength in the business—rising orders, record backlog, book-to-build above 1, strong January order rates, specific design wins, and demand exceeding supply—while deliberately holding the story back by framing 2022 expectations as measured, pragmatic, and cautious, noting ongoing challenges through Q1 and not fully embedding the current momentum into the guidance range. This posture appears in their own words as they describe the facts running ahead of the outlook they are willing to share. The restraint is not mere boilerplate but a visible choice to under-promise relative to the reported strength.
BCOV · Q1 2018 → YESThe question is: Does management BOTH report concrete, already-occurring strength AND visibly HOLD THE STORY BACK from that strength? YES Management reports concrete strength in Q1 2018: revenue $41.2M exceeded high end of guidance, adjusted EBITDA positive $900k well above high end, recurring dollar retention 103% (multi-year high), strong bookings across businesses/geographies, notable wins including large auto company deal, Europe best 3+ years, completed commodity pricing reset, and digital marketing/enterprise activity showing productivity gains. They visibly hold the story back: full-year revenue guidance $165-168M (roughly flat vs. Q1 run-rate implying ~$164.8M), Q2 revenue guidance $41.
PII · Q3 2017 → YESThe question is: Does management BOTH report concrete, already-occurring strength AND hold the story back from that strength? YES The transcript shows clear evidence of both elements in management's posture. They report concrete, already-occurring strength in the recent period—Q3 sales up 25% (adjusted), North American retail up 13% with RZR and NDN ahead, September as Polaris' highest retail month ever, August among top three 2017 months, off-road vehicles and Polaris retail up versus 2015 (not an easy comp), dealer inventory down 7%, and strong international/PG&A growth—while explicitly raising 2017 guidance (sales 18-19%, ORV/Snow mid-single digits, EPS $4.

More from the question bank

Ready-to-run scale already paid for and now Fresh change already executed, benefit mostlPersonal bests piling upOrder-of-magnitude gapQuietly replacing the old wayUpside surprise with durable, still-buildingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.